Feature|Videos|November 26, 2024
KinetiSol® Technology: Disrupting the Solid Amorphous Dispersion Landscape
Author(s)Austin Px
Elizabeth Hickman (Chief Business Officer, AustinPx) explains the company's approach to improving bioavailability, highlighting KinetiSol technology.
Elizabeth Hickman joined Pharmaceutical Technology to provide an overview of AustinPx, the company's bioavailability offerings, and KinetiSol technology, which represents a major breakthrough in amorphous dispersions. Learn more about:
- How AustinPx was created and the strategy behind taking a technology company and turning it into a CDMO;
- The origin of KinetiSol and how it can provide a faster, broader, and greener technology for amorphous solid dispersions;
- How KinetiSol can alleviate challenges associated with spray drying.
Related Content
Trending on Pharmaceutical Technology
1
Why Big Pharma Is Betting Billions on Protein Degraders for Cancer
2
Delaware Governor Meyer on Drug Pricing, Reshoring, and National Security
3
Enhancing Clinical Data Infrastructure for AI Research: A Strategic Guide for Pharma Professionals
4
Renewing Prosaic Generics for Cancer Treatment
5